These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17400592)

  • 41. Toward phonetic intelligibility testing in dysarthria.
    Kent RD; Weismer G; Kent JF; Rosenbek JC
    J Speech Hear Disord; 1989 Nov; 54(4):482-99. PubMed ID: 2811329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.
    Defazio G; Guerrieri M; Liuzzi D; Gigante AF; di Nicola V
    Neurol Sci; 2016 Mar; 37(3):443-9. PubMed ID: 26615536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predicting Intelligibility Deficits in Parkinson's Disease With Perceptual Speech Ratings.
    Chiu YF; Neel A
    J Speech Lang Hear Res; 2020 Feb; 63(2):433-443. PubMed ID: 32097080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple repair sequences in everyday conversations involving people with Parkinson's disease.
    Griffiths S; Barnes R; Britten N; Wilkinson R
    Int J Lang Commun Disord; 2015; 50(6):814-29. PubMed ID: 26152654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Speech and communication in Parkinson's disease: a cross-sectional exploratory study in the UK.
    Barnish MS; Horton SMC; Butterfint ZR; Clark AB; Atkinson RA; Deane KHO
    BMJ Open; 2017 May; 7(5):e014642. PubMed ID: 28554918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stop consonant production in isolated and repeated syllables in Parkinson's disease.
    Connor NP; Ludlow CL; Schulz GM
    Neuropsychologia; 1989; 27(6):829-38. PubMed ID: 2755591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of passage familiarity on intelligibility estimates of dysarthric speech.
    Beukelman DR; Yorkston KM
    J Commun Disord; 1980 Jan; 13(1):33-41. PubMed ID: 7354140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease.
    Cannito MP; Suiter DM; Beverly D; Chorna L; Wolf T; Pfeiffer RM
    J Voice; 2012 Mar; 26(2):214-9. PubMed ID: 22209057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How Well Does Diadochokinetic Task Performance Predict Articulatory Imprecision? Differentiating Individuals with Parkinson's Disease from Control Subjects.
    Karlsson F; Hartelius L
    Folia Phoniatr Logop; 2019; 71(5-6):251-260. PubMed ID: 31117108
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Classifications of vocalic segments from articulatory kinematics: healthy controls and speakers with dysarthria.
    Yunusova Y; Weismer GG; Lindstrom MJ
    J Speech Lang Hear Res; 2011 Oct; 54(5):1302-11. PubMed ID: 21646421
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.
    Smith CH; Patel S; Woolley RL; Brady MC; Rick CE; Halfpenny R; Rontiris A; Knox-Smith L; Dowling F; Clarke CE; Au P; Ives N; Wheatley K; Sackley CM
    Clin Linguist Phon; 2019; 33(10-11):1063-1070. PubMed ID: 31035809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preparing an E-learning-based Speech Therapy (EST) efficacy study: Identifying suitable outcome measures to detect within-subject changes of speech intelligibility in dysarthric speakers.
    Beijer LJ; Rietveld AC; Ruiter MB; Geurts AC
    Clin Linguist Phon; 2014 Dec; 28(12):927-50. PubMed ID: 25025268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Aug; 46(3):296-301. PubMed ID: 7278175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation Study.
    Moya-Galé G; Walsh SJ; Goudarzi A
    J Med Internet Res; 2022 Oct; 24(10):e40567. PubMed ID: 36264608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of levodopa on word intelligibility in Parkinson's disease.
    De Letter M; Santens P; Van Borsel J
    J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reliability and agreement of ratings of ataxic dysarthric speech samples with varying intelligibility.
    Sheard C; Adams RD; Davis PJ
    J Speech Hear Res; 1991 Apr; 34(2):285-93. PubMed ID: 2046353
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.